Rankings
▼
Calendar
VRTX FY 2024 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena
VRTX
Vertex Pharmaceuticals Incorporated
$129B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11.0B
+11.7% YoY
Gross Profit
$9.5B
86.1% margin
Operating Income
-$233M
-2.1% margin
Net Income
-$536M
-4.9% margin
EPS (Diluted)
$-2.08
Cash Flow
Operating Cash Flow
-$493M
Free Cash Flow
-$790M
Stock-Based Comp.
$699M
Balance Sheet
Total Assets
$22.5B
Total Liabilities
$6.1B
Stockholders' Equity
$16.4B
Cash & Equivalents
$4.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11.0B
$9.9B
+11.7%
Gross Profit
$9.5B
$8.6B
+10.3%
Operating Income
-$233M
$3.8B
-106.1%
Net Income
-$536M
$3.6B
-114.8%
← Q4 2023
All Quarters
Q1 2024 →